Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bill Deakin

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Molecular Psychiatry|November 18, 2025
Investigating the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequencesBill Deakin, Elizabeth Liddle, Mohanbabu Rathnaiah, et al.
Addiction Biology|March 2, 2017
Naltrexone ameliorates functional network abnormalities in alcohol-dependent individualsLaurel S Morris, Kwangyeol Baek, Roger Tait, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA studyKira Griffiths, Alice Egerton, Edward Millgate, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Molecular Psychiatry|November 18, 2025
Investigating the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequencesBill Deakin, Elizabeth Liddle, Mohanbabu Rathnaiah, et al.
Addiction Biology|March 2, 2017
Naltrexone ameliorates functional network abnormalities in alcohol-dependent individualsLaurel S Morris, Kwangyeol Baek, Roger Tait, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Pageof 7